June 1, 2023

Press Release: ComboMATCH investigators are translating robust pre-clinical evidence for new anti-cancer drug combinations into a series of early-phase clinical trials

May 31, 2023

Your daily guide to ASCO 2023 research presentations by ECOG-ACRIN and PrECOG

February 10, 2023

The January/February 2023 News from ECOG-ACRIN blog is now available

December 20, 2022

The November/December 2022 News from ECOG-ACRIN blog is now available

October 26, 2022

Press Release: NCI-MATCH cancer trial finds a promising signal for the AKT inhibitor ipatasertib

October 13, 2022

The September/October 2022 News from ECOG-ACRIN blog is now available

September 26, 2022

The Fall 2022 advocacy blog Considering Clinical Trials is now available

August 16, 2022

The August 2022 News from ECOG-ACRIN blog is now available

June 22, 2022

FDA approves dabrafenib plus trametinib for BRAF V600E-mutated tumors based on data from NCI-MATCH

ECOG-ACRIN Cancer Research Group